The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Collectively, the data from in vitro and in vivo studies using FUS, TDP-43, and C9orf72 models demonstrate that hUPF1 holds significant potential for treating the majority of patients with ALS and ...

Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025 LONDON, May 13, 2025 (GLOBE NEWSWIRE) ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Welcome to LetsPS! 🎨🖥️ Master Photoshop, Illustrator, and InDesign with step-by-step tutorials designed to help you create ...

Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today announced the results of preclinical studies ...

With the official trailer dropping Wednesday, here's a new key art poster for DC Studios and writer/director James Gunn's Superman.